Walensky hopeful Johnson & Johnson COVID-19 vaccine can be used again soon foxnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foxnews.com Daily Mail and Mail on Sunday newspapers.
Department of Health: Pause on Johnson & Johnson Vaccinations in Pennsylvania, FDA/CDC Announcement Highlights Vaccine Evaluation Process is Working
04/13/2021
Harrisburg, PA – The Pennsylvania Department of Health today notified all COVID-19 vaccine providers to pause administering doses of the Johnson & Johnson (Janssen) vaccine until at least April 20 following the recommendation out of an abundance of caution in a joint release from the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA).
The department is taking these steps as a precaution until the CDC and FDA have time to review six incidents of rare blood clots that occurred within two weeks of receiving Johnson & Johnson/Janssen vaccine. The CDC is convening an emergency meeting tomorrow of the Advisory Committee on Immunizations Practices to further review cases for any details on the significance of this rare occurrence.
Johnson & Johnson Vaccine Put on Hold fox8tv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fox8tv.com Daily Mail and Mail on Sunday newspapers.
The CDC and FDA are reviewing six incidents in which those who received doses of the J&J vaccine developed rare blood clots within two weeks, the department said.
Pa. tells providers to stop Johnson & Johnson shots while FDA reviews rare blood clotting cases
Updated 2:01 PM;
All Pennsylvania COVID-19 vaccine providers should pause giving doses of the Johnson & Johnson vaccine for at least a week, on the heels of a Tuesday recommendation from federal health officials, the state Health Department said
The department is taking the precautionary step as the Federal Drug Administration and Centers for Disease Control and Prevention review the cases of six women between the ages of 18 and 48, who had potentially serious blood clots 6 to 13 days after vaccination. This is a rare event as 6.8 million Americans have already received the Johnson & Johnson vaccine.